FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE and LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES

Overview

LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES is the #14 most commonly reported adverse reaction for FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, manufactured by GlaxoSmithKline LLC. There are 1,359 FDA adverse event reports linking FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE to LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES. This represents approximately 1.5% of all 88,399 adverse event reports for this drug.

Patients taking FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE who experience loss of personal independence in daily activities should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES is a less commonly reported adverse event for FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, but still significant enough to appear in the safety profile.

Other Side Effects of FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE

In addition to loss of personal independence in daily activities, the following adverse reactions have been reported for FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE:

• DYSPNOEA — 6,003 reports
• DRUG INEFFECTIVE — 3,905 reports
• ASTHMA — 3,867 reports
• COUGH — 3,317 reports
• WHEEZING — 2,583 reports
• WRONG TECHNIQUE IN DEVICE USAGE PROCESS — 2,236 reports
• PNEUMONIA — 2,058 reports
• PRODUCT COMPLAINT — 1,773 reports
• PRODUCT DOSE OMISSION ISSUE — 1,689 reports
• FATIGUE — 1,680 reports

Other Drugs Associated with LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES

The following drugs have also been linked to loss of personal independence in daily activities in FDA adverse event reports:

Does FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE cause LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES?

LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES has been reported as an adverse event in 1,359 FDA reports for FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES with FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE?

LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES accounts for approximately 1.5% of all adverse event reports for FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, making it a notable side effect.

What should I do if I experience LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES while taking FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE?

If you experience loss of personal independence in daily activities while taking FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages